0TDD.L
Novo Nordisk A/S
LSEUSDEQUITY
DELAYED
Last price
47.03
▲ 0.74 (1.60%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
46.20
Prev close
46.29
Day high
47.15
Day low
46.75
Volume
1.04K
Market cap
—
P/E (TTM)
0.15
52W range
46.75 – 142.93
Day trading desk
Gap from prior close
—
—
VWAP
46.84
+0.40% from price
Relative volume
2.01×
Unusually busy
Session range
2.24%
46.07 – 47.10
Position in range
93%
Near session high
ATR (14D)
—
Daily true range
Prior day high
—
PDH
Prior day low
—
PDL
Bid / ask spread
—
Quote not published
Session volume
44.99K
Avg 22.41K
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on 0TDD.L open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
132.84K
Total on file
Fundamentals
Market cap—
Enterprise value$303.57B
Revenue (TTM)$329.43B
Gross profit$270.09B
EBITDA$173.68B
Net income$116.44B
EPS (TTM)$3.03
Free cash flow$37.67B
Total cash$44.98B
Total debt$140.13B
Book value / share$7.81
Shares outstanding2.41B
Float3.17B
Short % of float—
Dividend yield—
Beta (5Y)0.35
Valuation & profitability ratios
Trailing P/E0.15
Forward P/E—
PEG ratio—
Price / sales—
Price / book6.01
EV / revenue0.92
EV / EBITDA1.75
Gross margin81.99%
Operating margin42.54%
Profit margin35.35%
Return on equity59.81%
Return on assets18.73%
Debt / equity63.33
Current ratio0.87
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $72.91B | -2.8% |
| Next quarter | — | — | $73.96B | -6.5% |
| Current year | — | — | $298.45B | -3.4% |
| Next year | — | — | $303.59B | +1.7% |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
ConsensusNONE
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders0.00%
Held by institutions9.90%
Institutions holding1.63K
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
—
—
SMA 20
—
—
SMA 50
—
—
SMA 100
—
—
SMA 200
—
—
EMA 12
—
—
EMA 26
—
—
EMA 50
—
—
RSI (14)
—
—
MACD (12,26,9)
—
Hist —
ATR (14)
—
—
Realised vol 30D
—
Annualised
Bollinger upper
—
20, 2σ
Bollinger lower
—
20, 2σ
50 / 200 cross
—
—
Trend bias
—
—
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
—
—
Correlation to SPY
—
—
Realised vol 30D
—
Annualised
Market vol 1Y
—
SPY, annualised
Max drawdown 1Y
—
Peak to trough
Max drawdown 5Y
—
Peak to trough
ATR 14
—
Average true range
Beta (reported)
0.35
5Y monthly, from filing
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Mar 2, 26 | Goldman Sachs | DOWNGRADE | Buy | Neutral |
| Feb 24, 26 | JP Morgan | DOWNGRADE | Overweight | Neutral |
| Jan 9, 26 | CICC | INITIATED | — | Outperform |
| Dec 8, 25 | Argus Research | DOWNGRADE | Buy | Hold |
| Nov 28, 25 | Goldman Sachs | MAINTAINED | Buy | Buy |
| Nov 25, 25 | BMO Capital | MAINTAINED | Market Perform | Market Perform |
| Nov 24, 25 | HSBC | DOWNGRADE | Buy | Hold |
| Oct 14, 25 | BMO Capital | MAINTAINED | Market Perform | Market Perform |
| Oct 2, 25 | HSBC | UPGRADE | Hold | Buy |
| Sep 29, 25 | Morgan Stanley | DOWNGRADE | Equal-Weight | Underweight |
| Sep 17, 25 | Berenberg | UPGRADE | Hold | Buy |
| Aug 19, 25 | TD Cowen | MAINTAINED | Buy | Buy |
Dividends & splits
Forward rate—
Forward yield—
5-year avg yield—
Payout ratio—
Ex-dividend date—
Next pay date—
Last split2:1
Split dateSep 20, 2023
Headlines
Share repurchase programme: Transactions of week 34 2026
GlobeNewswire · 8m ago
Hindustan Coca-Cola Beverages Certified as a Top Employer in India for 2026 by Top Employers Institute
PR Newswire · 11m ago
Asian shares mostly decline as bond market pressure mounts
Associated Press · 12m ago
INDONESIAN HEALTHCARE TRAVEL TO MALAYSIA HITS RECORD RM2.2 BILLION AS MHX RETURNS TO YOGYAKARTA
PR Newswire · 17m ago
BW Offshore: Second quarter and first half results 2026
GlobeNewswire · 17m ago
Sampo plc’s share buybacks week 34/2026
GlobeNewswire · 17m ago
Elon Musk's Tesla Has 'Massive Advantage' Before Selling Optimus in the Market, Says This Analyst — Crypto Prediction Market Weighs 2026 Launch Odds
Benzinga Prediction Markets · 18m ago
SPCX Stock Slides Overnight: Musk Maps Falcon Wind-Down For Starship — Rare ‘Sell’ Call Sees 27% Downside
Stocktwits · 19m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.